Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have ...

Results demonstrated the mean total medical costs per patient per year decreased significantly after patients began ...

Ozempic (semaglutide) may impact kidney health in certain people, especially those with diabetes. Learn more about what the ...

Topline results were announced from a phase 3 clinical trial evaluating subcutaneous semaglutide in patients with MASH and liver fibrosis.

Topline results were announced from a phase 3 clinical trial evaluating subcutaneous semaglutide in obesity and knee osteoarthritis.

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have ...

A recent poll found that about 15.5 million Americans have used injectable diabetes medicines like Ozempic and Wegovy to lose ...

Recent studies reinforce that weight loss is not simply an esthetic consideration. It has very real benefits in terms of ...

Specifically, the study — as published in “Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association” — has linked ...

Thousands have injected themselves with compounded versions of the drug sold by pharmacies and 'med spas' amid nationwide ...

Results from a retrospective cohort study show lower all-cause mortality and fewer hospitalizations and intestinal ...

Novo Nordisk’s net profit of $3.94bn represents a 21% increase from Q3 2023. Net sales in the quarter jumped by the same ...